Skip to content

Development of a Computerized Adaptive Test (CAT) for Evaluation of Sleep, Fatigue and Quality of Life in Patients With Chronic Pain

Desenvolvimento de Teste Adaptativo Computadorizado (CAT) Para avaliação do Sono, Fadiga e Qualidade de Vida em Pacientes Com Dor crônica

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03410589
Acronym
CAT
Enrollment
308
Registered
2018-01-25
Start date
2019-01-01
Completion date
2019-09-20
Last updated
2025-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Brief summary

The purpose of this study is to evaluate quality of life, sleep and fadigue in patients with chronic pain using an Item-Response Theory methodology and also generating a Computer Adaptive Testing System

Interventions

OTHERSinlge arm

application of scales for evaluation of sleep, fatigue and quality of life - Observational study

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

be able to read Portuguese be able to write Portuguese being in treatment for chronic pain

Exclusion criteria

hearing impairment that impairs ability to respond to tests visual impairment that impairs ability to respond to tests physical impairment that impairs ability to respond to tests cognitive impairment that impairs ability to respond to tests

Design outcomes

Primary

MeasureTime frameDescription
sleep disordersWithin 1 month before the study startscore in Pittsburgh Sleep Quality
fatigueWithin 7 days before the study startscore of Multidimensional Fatigue Inventory
measurement quality of liveWithin 1 month before the study startmeasurement quality of live will be score the using SF-12

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026